One of China’s leading vaccine developers is working on a plan to inoculate students going overseas with Covid-19 shots that are yet to get regulatory approval, according to people familiar with the matter, as the country pushes scientific boundaries in the race for a viable immunisation.
China National Biotec Group Co., or CNBG, a subsidiary of state-owned Sinopharm Group Co, is in talks with the Chinese government about giving students headed abroad to study its experimental vaccines, said the people, who asked not to be identified as they’re not authorised to speak publicly. Various government agencies are still working on the